The table below shows Dianthus Therapeutics, Inc. /DE/'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
$396.00K
$193.00K
$1.16M
$2.17M
$1.86M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$34.53M
$32.49M
$26.25M
$27.00M
$25.54M
$18.07M
SG&A
DNTH annual revenue (10-K history)
Dianthus Therapeutics, Inc. /DE/ reported annual revenue of $2.04M for fiscal year 2025. That is down 67.3% from $6.24M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.